Introduction
T1D, T2D, type 2 diabetes
TYPE 1 DIABETES, TYPE 2 DIABETES, HYPOGLYCAEMIA
Type 1 diabetes (T1D) is an autoimmune condition characterised by pancreatic beta cell destruction, absolute insulin deficiency, and impaired glucose metabolism [Dietary carbohydrates significantly influence post-prandial blood glucose levels and individuals with T1D are recommended to quantify carbohydrate intake (known as ‘carbohydrate counting’) to predict rises in post-prandial glucose levels and administer appropriate insulin dosages for meals and snacks [In adults with type 2 diabetes (T2D), randomised controlled trials have repeatedly demonstrated that low-carbohydrate (LC) diets (≤130 g/day or 26% TEI from carbohydrates) achieve greater reductions in HbA1c and anti-glycaemic medications, with greater increases in HDL-cholesterol and decreases in triglycerides, when compared to traditional HC diets [The objective of this study was to compare the effects of a professionally supported LC diet intervention with habitual diets higher in carbohydrates on clinical markers including HbA1c, glycaemic variability, frequency of hypoglycaemia, total daily insulin (TDI), and quality of life in adults with T1D. It was hypothesised that that a LC diet intervention would achieve greater improvements in clinical markers of T1D management.